Psilocybin
Silo Wellness: Revenue Generating and Vertically Integrated Wellness Products and Retreats
Silo Wellness (CSE:SILO), (FRA: 3K70) has launched its campaign on the Investing News Network
The post Silo Wellness: Revenue Generating and Vertically…

Silo Wellness (CSE:SILO), (FRA: 3K70) offers multiple revenue streams including specialized psychedelic wellness retreats in Oregon and Jamaica, a patent-pending nasal spray, its premium Silo Wellness retail brand and psychedelic mushroom cultivation in Jamaica.
The company has a landmark, multi-year license agreement with the family of legendary musician Bob Marley for exclusive worldwide rights to brand, market and sell distinct product lines of functional and psychedelic mushrooms. Through this partnership, Silo Wellness aims to provide quality branded products with instant name recognition and global visibility.
Silo Wellness’ Company Highlights
- Silo Wellness operates psychedelic mushroom cultivation, a premium retail brand, patent-pending nasal spray and psychedelic-based wellness retreats in Oregon and Jamaica.
- The psychedelic nasal spray presents the company with potential IP positioning and an early head start of bringing a unique product like this to the psychedelic market space.
- Silo Wellness offers multiple retreats, including a holistic and mindfulness-oriented experience in Jamaica and a medically-guided ketamine experience in Oregon. The company announced it is collaborating with Kaivalya Kollectiv to integrate 5-MeO-DMT into to of its upcoming retreats in Jamaica.
- The company is looking to expand its retail brand from the six tinctures currently offered on its online store, Silo Reboot. Silo Wellness is looking to launch a worldwide IP partnership with international wellness and lifestyle branding partners.
- A multi-year license agreement with the family of legendary musician Bob Marley for exclusive worldwide rights to brand, market and sell a distinct product line of functional and psychedelic mushrooms.
- Signed its first commercial transaction with Jungle Med to exclusively manufacture, promote, advertise, distribute and sell the nasal spray in Colombia and Brazil.
The post Silo Wellness: Revenue Generating and Vertically Integrated Wellness Products and Retreats appeared first on Investing News Network.
mushroom ketamine dmt psychedelic investing investors cse silo
-
Psilocybin11 hours ago
Microsoft brings OpenAI’s DALL-E image creator to the new Bing
-
Psilocybin7 hours ago
Lucy Scientific Acquires Psychedelic Assets from Wesana Health
-
Psilocybin8 hours ago
Are Psychedelics a New Paradigm or Business as Usual?
-
DMT5 hours ago
New Study Gives Most Advanced View of the Brain on Psychedelics
-
Markets & Investing5 hours ago
Tom McDonald, CEO of Clerkenwell Health, Sits in the Investor Hotseat on March 30th
-
Psilocybin5 hours ago
First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder